The Bulls N' Bears ASX Runner of the Week is… Argent BioPharma, after striking a smart licensing deal for its CannEpil epilepsy drug that wipes out a major debt overhang while retaining royalties to its blue-sky opportunity. Peregrine Gold charged higher on the discovery of extensive gold-bearing paleo gravels at its Newman project in WA, NewPeak Metals surged after hitting a broad 663m gold-zinc-silver intercept in the first hole at its Las Opeñas project in Argentina and Caspin Resources ran on thick high-grade tin results from the new Errol's Zone at its Bygoo project in NSW.
Our board moves wrap includes Gemma Tually, Alison Terry, Ben Kim, YeongJin Heo, Brian Thomas, Ian Middlemas, Mark Pearce, Gregory Hancock, and Conrad Todd.
Peregrine Gold shares surged nearly 23 per cent on the news that seasoned mining investor Mark Creasy would take up a substantial stake in the Pilbara-focused explorer.